Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial-Reference-Cited by-同舟云学术

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial

Published:2007-07 Issue:1 Volume:52 Page:134-141
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Dogliotti Luigi,Cartenì Giacomo,Siena Salvatore,Bertetto Oscar,Martoni Andrea,Bono Aldo,Amadori Dino,Onat Haluk,Marini Luca

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

2. Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study;Harker;J Clin Oncol,1985

3. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium;Sternberg;J Urol,1988

4. A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract;Hillcoat;J Clin Oncol,1989

5. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience;Tannock;J Urol,1989

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study;ESMO Open;2024-09

2. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21

3. Eligibility Criteria for Different Platinum-Based Chemotherapy Regimens in Metastatic Urothelial Carcinoma;Cureus;2024-08-09

4. Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer;Nature Communications;2024-08-02

5. A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial;Methods and Protocols;2024-07-29